Crescita Reports Third Quarter 2023 Results : vimarsana.com

Crescita Therapeutics Inc. ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the third quarter ended September 30, 2023 ("Q3-2023"). All amounts...

Related Keywords

Toronto , Ontario , Canada , Canadian , Croma Pharma Gmb , Serge Verreault , International Financial Reporting Standards , Aegis Pharmaceuticals , Services Manufacturing , Crescita Therapeutics Inc , Limitations Of Summary Financial Results Press , Cantabria Labs Inc , Toronto Stock Exchange , Company Consolidated Audited Financial , Taro Pharmaceuticals Inc , Reports Third Quarter , Taro Pharmaceuticals , Commercial Skincare , Cantabria Labs , Croma Pharma , Concerning Limitations , Summary Financial Results Press , Consolidated Audited Financial Statements , Annual Information Form ,